ASCO Annual Report Names Significant Clinical Research Advances Of Past Year
Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial
Tykerb Plus Herceptin Better Than Monotherapy, Study Says
Bisphosphonates May Reduce Recurrent Breast Cancer
Study Finds High-Risk Women Reluctant To Take Tamoxifen
Cervical Cancer Screening Can Be Done Later, Less Often
No Benefit For Cetuximab In Early-Stage Colon Cancer
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Banished from the institute he founded, separated from his lab materials, Tom Curran sues Children’s Mercy
Whistleblower lawsuit alleges wrongful firing - Tom Sellers steps down as director of OHSU Knight, replaced by Lisa Coussens
Shivaani Kummar recently named interim CEO - DOD cancer research programs face 57% funding cut in year-long continuing resolution
Pancreatic, lung, kidney cancer research programs eliminated - Only half of adolescents and young adults with cancer get fertility counseling before treatment
Oncofertility consult is an oft-overlooked standard of care - Thomas B. Tomasi Jr., Roswell Park president and CEO from 1986 to 1996, dies at 97
An architect of today’s Roswell Park - Rathmell steps down at NCI as Trump team considers candidates to replace her
Wafik El-Deiry, Harvey Risch have been interviewed
